Open Access Open Access  Restricted Access Subscription or Fee Access

Study on Healthcare Workers in a Tertiary Institute of Uttarakhand on Possible Adverse Effects after COVID-19 Vaccination

Akansha Oli, Ashutosh Bhardwaj, Kuldeep Martolia, Shiv Kumar Yadav, Mohita Bohra

Abstract


The occurrence of a devastating pandemic of severe acute respiratory syndrome coronavirus-2 (SARS- CoV-2) infection, which emerged in the year 2019 in Wuhan, China, has come out as a primary concern all over the world. Many measures were adopted to prevent its spread, but the role of vaccines is inevitable. Understanding the importance of vaccines in the current situation, Government of India launched the COVID-19 vaccine drive on Jan 16, 2021. The two widely distributed vaccines in India are Covishield, and Covaxin. Vaccines may produce some untoward effects which are mostly mild and subside on their own. Based on the definition provided by the World Health Organization, an adverse event following immunization refers to any unfavorable medical incident that occurs after receiving a vaccine, and it may or may not be directly caused by the vaccine itself. If not quickly and successfully managed, can subvert trust in immunization and eventually have sensational ramifications for vaccination inclusion and sickness occurrence. Thus, it can be said that vaccine safety is one of the most important aspects to be considered in the utilization of present and future development of any vaccine type. Hence given this pandemic, it is essential to evaluate the safety measures of COVID-19 vaccines. The present study was conducted among 450 healthcare workers in a government medical college in Uttarakhand state, India who took both doses of corona vaccine, for evaluation of possible adverse effects following COVID-19 vaccination. Data was collected retrospectively through a self- prepared questionnaire. The vaccines were found to be safe as the majority of participants that is, 59.8% suffered from minor, 3.78% severe, and 0.00% from serious adverse events following immunization (AEFI). Only individuals between the ages of 15–24 years experienced severe AEFI. The incidence of AEFI was higher among the younger population as compared to the older population. A greater percentage of females reported AEFI in comparison to males. AEFI after the first dose of vaccine were more in comparison to the second dose and both doses. The vaccines are considered safe as none of the case required hospitalization.

Keywords


Adverse events following immunization, COVID-19, Covishield, Covaxin, vaccination, World Health Organization

Full Text:

PDF

References


Microbial Evolution and coadaptation: A tribute to the life and scientific legacies of Joshua Lederberg: Workshop Summary. Infectious Disease Emergence: Past, Present, and Future. USA: National Academies Press; 2009. Available from: https://www.ncbi.nlm.nih.gov/books/NBK457 14/ (cited on 2023 Jul 14).

Lindahl JF, Grace D. The consequences of human actions on risks for infectious diseases: A review. Infect Ecol Epidemiol. 2015; 5: 30048.

Bengis RG, Leighton FA, Fischer JR, Artois M, Mörner T, Tate CM. The role of wildlife in emerging and re-emerging zoonoses. Rev Sci Tech. 2004; 23(2): 497–511p.

Manning F. A Dictionary of Epidemiology, Fourth Edition - Edited by John M. Last, Robert A. Spasoff, and Susan S. Harris. American Journal of Epidemiology. 2001; 154(1): 93–94p. Available from: https://www.academia.edu/27424319/A_Dictionary_of_Epidemiology_Fourth_Edition_Edi ted_by_John_M_Last_Robert_A_Spasoff_and_Susan_S_Harris [cited on 2023 Jul 14].

Ahn JY, Sohn Y, Lee SH, Cho Y, Hyun JH, Baek YJ, Jeong SJ, Kim JH, Ku NS, Yeom JS, Roh J, Ahn MY, Chin BS, Kim YS, Lee H, Yong D, Kim HO, Kim S, Choi JY. Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea. J Korean Med Sci. 2020; 35(14): e149p.

Kaur SP, Gupta V. COVID-19 Vaccine: A comprehensive status report. Virus Res. 2020; 288: 198114p.

Ministry of Health and Family Welfare. Covid 19 vaccines- operational guidelines; Chapter 10. New Delhi: Government of India; 2021. 106p. Available from: https://www.mohfw.gov.in/pdf/ COVID19VaccineOG111Chapter16.pdf. [cited on 2022 Sept 28].

Siegrist CA. Mechanisms underlying adverse reactions to vaccines. J Comp Pathol. 2007; 137(1): 46–50p. doi: 10.1016/j.jcpa.2007.

Hervé C, Laupèze B, Del Giudice G, Didierlaurent AM, Tavares Da Silva F. The how's and what's of vaccine reactogenicity. NPJ Vaccines. 2019; 4: 39p.

Budhiraja S, Akinapelli R. Pharmacovigilance in vaccines. Indian J Pharmacol. 2010; 42(2): 117p. doi: 10.4103/0253-7613.64488.

Joshi RK, Muralidharan CG, Gulati DS, Mopagar V, Dev JK, Kuthe S, Rather AA, Sahoo AK. Higher incidence of reported adverse events following immunisation (AEFI) after first dose of COVID-19 vaccine among previously infected health care workers. Med J Armed Forces India. 2021; 77(2): S505–S507.

Jeon M, Kim J, Oh CE, Lee JY. Adverse Events Following Immunization Associated with Coronavirus Disease 2019 Vaccination Reported in the Mobile Vaccine Adverse Events Reporting System. J Korean Med Sci. 2021; 36(17): e114p.

Harris T, Nair J, Fediurek J, Deeks SL. Assessment of sex-specific differences in adverse events following immunization reporting in Ontario, 2012-15. Vaccine. 2017; 35(19): 2600–2604p. doi: 10.1016/j.vaccine.2017.03.035.

Jayadevan R, Shenoy R, Anithadevi TS. Survey of symptoms following COVID-19 vaccination in India. Medrvix [Internet]; 2021 Feb 12. Available from: https://www.medrxiv.org/content/10.1101/ 2021.02.08.21251366v1 [cited on 2023 Jul 14].

Potluri T, Fink AL, Sylvia KE, Dhakal S, Vermilion MS, Steeg LV, Deshpande S, Narasimhan H, Klein SL. Age-associated changes in the impact of sex steroids on influenza vaccine responses in males and females. NPJ Vaccines. 2019; 4: 29p.

Parida SP, Sahu DP, Singh AK, Alekhya G, Subba SH, Mishra A, Padhy BM, Patro BK. Adverse events following immunization of COVID-19 (Covaxin) vaccine at a tertiary care center of India. J Med Virol. 2022; 94(6): 2453–2459p. doi: 10.1002/jmv.27655

Wang J, Tong Y, Li D, Li J, Li Y. The Impact of Age Difference on the Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis. Front Immunol. 2021; 12: 758294.

Mohfw.gov.in. (2019). Home | Ministry of Health and Family Welfare | GOI [Online] Available from: https://main.mohfw.gov.in/.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2023 Research & Reviews: A Journal of Immunology

This Journal archive has been shifted to: https://journals.stmjournals.com/archive/rrjoi/